Intro to COVID-19: Enforcement Action Guidelines, Legal Liabilities and Concerns
This session will address FDA’s enforcement discretion, including what it is an how it has been utilized by FDA during the COVID-19 health emergency. Ways to protect your company from liability considerations will also be discussed.
Sonali P. Gunawardhana, Of Counsel, Shook, Hardy & Bacon LLP
Angela M. Seaton, Partner, Shook, Hardy & Bacon LLP
This session was recorded as part of FDLI’s virtual course, “COVID-19: Introduction to FDA’s Existing Legal Authorities and Emerging Issues” on August 18, 2020.
- +$100 for nonmembers
Legal issues regarding the response to COVID-19 is a rapidly evolving field. It is important to note the program recording date given that FDA guidance may have revised or been updated. For questions, please check the FDA website at: https://www.fda.gov/home
Virtual Learning FAQ